Company intelligence / Profile preview
Cipla
Mumbai, Maharashtra, Indiacipla.com ↗
- Ownership
- Public · CIPLA
- Employees
- ~25000
- Development stage
- Commercial
01
Overview
Cipla has a broad commercial portfolio with over 1,500 products, including generics and branded medicines across more than a dozen therapeutic areas. It leads in antiretroviral drug manufacturing globally and pioneered affordable triple therapy for HIV/AIDS. Recent clinical innovation includes pediatric fixed-dose ARV combinations developed with global partners.
- Therapeutic areas
- PulmonologyCardiovascularEndocrinologyDermatologyOncologyNeurologyInfectious Diseases
- Modalities
- Small molecules (generics and branded drugs)BiosimilarsInhalation therapies/devices (e.g., metered-dose inhalers)Fixed-dose combinations
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Gilead Sciences – Remdesivir licensing for COVID treatment in IndiaTakeda Pharmaceutical Company – Vonoprazan commercialization licenseFormosa Pharmaceuticals – Clobetasol Propionate Ophthalmic Suspension commercialization agreementDrugs for Neglected Diseases initiative (DNDi), Unitaid – Pediatric ARV development partnership
04
Financials
- Market cap
- $16.6M
- Total revenue
- $0
- Enterprise value
- $1.6M
Beyond the preview
Go deeper on Cipla.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cipla.